BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3963004)

  • 1. In vivo bone lead measurements: a rapid monitoring method for cumulative lead exposure.
    Wielopolski L; Ellis KJ; Vaswani AN; Cohn SH; Greenberg A; Puschett JB; Parkinson DK; Fetterolf DE; Landrigan PJ
    Am J Ind Med; 1986; 9(3):221-6. PubMed ID: 3963004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo measurements of bone lead--a comparison of two x-ray fluorescence techniques used at three different bone sites.
    Somervaille LJ; Nilsson U; Chettle DR; Tell I; Scott MC; Schütz A; Mattsson S; Skerfving S
    Phys Med Biol; 1989 Dec; 34(12):1833-45. PubMed ID: 2616639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing bone lead content by chelation treatment in chronic lead poisoning: an in vivo X-ray fluorescence and bone biopsy study.
    Batuman V; Wedeen RP; Bogden JD; Balestra DJ; Jones K; Schidlovsky G
    Environ Res; 1989 Feb; 48(1):70-5. PubMed ID: 2492468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing bone lead concentration in a suburban community assessed by noninvasive K x-ray fluorescence.
    Kosnett MJ; Becker CE; Osterloh JD; Kelly TJ; Pasta DJ
    JAMA; 1994 Jan; 271(3):197-203. PubMed ID: 8277545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects.
    Somervaille LJ; Chettle DR; Scott MC; Tennant DR; McKiernan MJ; Skilbeck A; Trethowan WN
    Br J Ind Med; 1988 Mar; 45(3):174-81. PubMed ID: 3348993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead in vertebral bone biopsies from active and retired lead workers.
    Schütz A; Skerfving S; Christoffersson JO; Ahlgren L; Mattson S
    Arch Environ Health; 1987; 42(6):340-6. PubMed ID: 3439810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone lead, hypertension, and lead nephropathy.
    Wedeen RP
    Environ Health Perspect; 1988 Jun; 78():57-60. PubMed ID: 3203647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chelatable lead versus lead in human trabecular and compact bone.
    Schütz A; Skerfving S; Christoffersson JO; Tell I
    Sci Total Environ; 1987 Mar; 61():201-9. PubMed ID: 3576178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two in vitro methods of bone lead analysis and the implications for in vivo measurements.
    Somervaille LJ; Chettle DR; Scott MC; Aufderheide AC; Wallgren JE; Wittmers LE; Rapp GR
    Phys Med Biol; 1986 Nov; 31(11):1267-74. PubMed ID: 3786412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-invasive determination of bone lead in human body using X-ray fluorescence excited by 109Cd].
    Huang SB; Tian L; Cheng HS; Pei P
    Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Nov; 24(11):1470-2. PubMed ID: 15762508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of in vivo X-ray fluorescence determination of skeletal lead stores.
    Sokas RK; Besarab A; McDiarmid MA; Shapiro IM; Bloch P
    Arch Environ Health; 1990; 45(5):268-72. PubMed ID: 2124094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of noninvasive analysis of lead in the human tibia by soft x-ray fluorescence.
    Wielopolski L; Rosen JF; Slatkin DN; Vartsky D; Ellis KJ; Cohn SH
    Med Phys; 1983; 10(2):248-51. PubMed ID: 6865866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo measurement of lead in bone using x-ray fluorescence.
    Somervaille LJ; Chettle DR; Scott MC
    Phys Med Biol; 1985 Sep; 30(9):929-43. PubMed ID: 4048276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chelated lead and bone lead.
    Tell I; Somervaille LJ; Nilsson U; Bensryd I; Schütz A; Chettle DR; Scott MC; Skerfving S
    Scand J Work Environ Health; 1992 Apr; 18(2):113-9. PubMed ID: 1604271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo measurements of lead in bone at four anatomical sites: long term occupational and consequent endogenous exposure.
    Erkkilä J; Armstrong R; Riihimäki V; Chettle DR; Paakkari A; Scott M; Somervaille L; Starck J; Kock B; Aitio A
    Br J Ind Med; 1992 Sep; 49(9):631-44. PubMed ID: 1390269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity.
    Roels HA; Hoet P; Lison D
    Ren Fail; 1999; 21(3-4):251-62. PubMed ID: 10416202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo measurements of lead in bone in long-term exposed lead smelter workers.
    Gerhardsson L; Attewell R; Chettle DR; Englyst V; Lundström NG; Nordberg GF; Nyhlin H; Scott MC; Todd AC
    Arch Environ Health; 1993; 48(3):147-56. PubMed ID: 8333784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone.
    Hu H; Pepper L; Goldman R
    Am J Ind Med; 1991; 20(6):723-35. PubMed ID: 1805610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeatability of tibia lead measurement by X-Ray fluorescence in a battery-making workforce.
    Todd AC; Ehrlich RI; Selby P; Jordaan E
    Environ Res; 2000 Nov; 84(3):282-9. PubMed ID: 11097802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo measurement of cortical bone lead using polarized x rays.
    Wielopolski L; Rosen JF; Slatkin DN; Zhang R; Kalef-Ezra JA; Rothman JC; Maryanski M; Jenks ST
    Med Phys; 1989; 16(4):521-8. PubMed ID: 2770625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.